Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,074) with videos related to
Page
of 108
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2015
Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer
M Takeda, K Sakai, M Terashima, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
July 1, 1998
Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan
T Nishimura, M Takeda, Y Nakamura, et al.
Nature Cell Biology
|
December 10, 1999
Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response
T Katayama, K Imaizumi, N Sato, et al.
ESMO Open
|
February 14, 2022
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients
K J O'Byrne, K H Lee, S-W Kim, et al.
Translational Psychiatry
|
October 22, 2014
Common variants at 1p36 are associated with superior frontal gyrus volume
R Hashimoto, M Ikeda, F Yamashita, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
February 18, 1999
Basic and clinical studies on ApoE gene typing by line probe assay (LiPA) as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan
T Nishimura, M Takeda, K Shinosaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
T Yoshino, G Pentheroudakis, S Mishima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 14, 2017
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
K Haratani, H Hayashi, T Tanaka, et al.
Neurology
|
December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease
Hiroshi Kase, S Aoyama, M Ichimura, et al.
Molecular Psychiatry
|
January 20, 2016
Abnormal asymmetries in subcortical brain volume in schizophrenia
N Okada, M Fukunaga, F Yamashita, et al.
Page
of 108
Search research articles
Search
Showing results (1061-1070 of 1,074) with videos related to
Sort By:
Page
of 108
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2015
Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer
M Takeda, K Sakai, M Terashima, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
July 1, 1998
Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan
T Nishimura, M Takeda, Y Nakamura, et al.
Nature Cell Biology
|
December 10, 1999
Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response
T Katayama, K Imaizumi, N Sato, et al.
ESMO Open
|
February 14, 2022
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients
K J O'Byrne, K H Lee, S-W Kim, et al.
Translational Psychiatry
|
October 22, 2014
Common variants at 1p36 are associated with superior frontal gyrus volume
R Hashimoto, M Ikeda, F Yamashita, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
February 18, 1999
Basic and clinical studies on ApoE gene typing by line probe assay (LiPA) as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan
T Nishimura, M Takeda, K Shinosaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
T Yoshino, G Pentheroudakis, S Mishima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 14, 2017
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
K Haratani, H Hayashi, T Tanaka, et al.
Neurology
|
December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease
Hiroshi Kase, S Aoyama, M Ichimura, et al.
Molecular Psychiatry
|
January 20, 2016
Abnormal asymmetries in subcortical brain volume in schizophrenia
N Okada, M Fukunaga, F Yamashita, et al.
Page
of 108